MA46580A - Vecteurs de recombinaison exprimant des antigènes de virus de la grippe aviaire et utilisations associées - Google Patents
Vecteurs de recombinaison exprimant des antigènes de virus de la grippe aviaire et utilisations associéesInfo
- Publication number
- MA46580A MA46580A MA046580A MA46580A MA46580A MA 46580 A MA46580 A MA 46580A MA 046580 A MA046580 A MA 046580A MA 46580 A MA46580 A MA 46580A MA 46580 A MA46580 A MA 46580A
- Authority
- MA
- Morocco
- Prior art keywords
- influenza virus
- avian influenza
- vectors expressing
- virus antigens
- recombination vectors
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 230000006798 recombination Effects 0.000 title 1
- 238000005215 recombination Methods 0.000 title 1
- 241000712461 unidentified influenza virus Species 0.000 title 1
- 239000013598 vector Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
- C12N2710/16341—Use of virus, viral particle or viral elements as a vector
- C12N2710/16343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24041—Use of virus, viral particle or viral elements as a vector
- C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Pulmonology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662410885P | 2016-10-21 | 2016-10-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA46580A true MA46580A (fr) | 2019-08-28 |
Family
ID=60452725
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA046580A MA46580A (fr) | 2016-10-21 | 2017-10-20 | Vecteurs de recombinaison exprimant des antigènes de virus de la grippe aviaire et utilisations associées |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US11058761B2 (fr) |
| EP (2) | EP3528842B1 (fr) |
| KR (1) | KR20190073460A (fr) |
| CN (1) | CN110072548A (fr) |
| CA (1) | CA3041304A1 (fr) |
| ES (1) | ES3073368T3 (fr) |
| IL (1) | IL266148B2 (fr) |
| JO (1) | JOP20190088A1 (fr) |
| MA (1) | MA46580A (fr) |
| MX (1) | MX385918B (fr) |
| MY (1) | MY191322A (fr) |
| PH (1) | PH12019500854A1 (fr) |
| RU (1) | RU2761869C2 (fr) |
| SA (1) | SA519401606B1 (fr) |
| TN (1) | TN2019000127A1 (fr) |
| TW (1) | TW201829454A (fr) |
| WO (1) | WO2018075977A1 (fr) |
| ZA (1) | ZA201902525B (fr) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109310750B (zh) | 2016-06-17 | 2022-08-12 | 英特维特国际股份有限公司 | 编码传染性喉气管炎病毒和传染性法氏囊病病毒抗原的重组非致病性马立克氏病病毒构建体 |
| JOP20190088A1 (ar) * | 2016-10-21 | 2019-04-21 | Us Agriculture | نواقل مؤتلفة للتعبير عن مولدات مضاد فيروس انفلونزا الطيور و استخداماتها |
| CN111542599A (zh) | 2017-10-12 | 2020-08-14 | 英特维特国际股份有限公司 | 编码多种异源抗原的重组非致病性马尔克氏病病毒构建体 |
| BR112021012032A2 (pt) * | 2018-12-21 | 2021-11-16 | Ceva Sante Animale | Herpesvírus aviários recombinantes contendo múltiplos genes estranhos |
| CN114616325A (zh) * | 2019-09-11 | 2022-06-10 | 硕腾服务有限责任公司 | 表达禽病原体抗原的重组火鸡疱疹病毒载体和其用途 |
| CN113827713B (zh) * | 2020-06-23 | 2024-07-05 | 普莱柯生物工程股份有限公司 | 一种抗h7亚型禽流感病毒的疫苗组合物、及其制备方法和应用 |
| CN113603754B (zh) * | 2021-08-23 | 2024-05-24 | 福建省农业科学院畜牧兽医研究所 | 一种水禽h5n8亚型流感病毒ha重组蛋白及其制备方法与应用 |
| CN113913394B (zh) * | 2021-10-19 | 2022-06-21 | 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） | 人工重组的h5n6流感病毒及其制备方法和应用 |
| CN114524862B (zh) * | 2021-12-16 | 2022-12-27 | 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） | 禽流感(h5+h7)三价dna疫苗的构建及其应用 |
| KR102846432B1 (ko) | 2022-11-15 | 2025-08-18 | 대한민국 | 재조합 h5n1 조류 인플루엔자 바이러스 및 이를 이용한 고병원성 조류 인플루엔자 백신 및 제조방법 |
| CN120555370A (zh) * | 2024-02-29 | 2025-08-29 | 诗华动保科技(杭州)有限公司 | 重组hvt及其应用 |
| KR20250137778A (ko) | 2024-03-11 | 2025-09-19 | 대한민국(농림축산식품부 농림축산검역본부장) | Clade 2.3.2.1d에 속하는 재조합 조류 인플루엔자 A 바이러스 합성주, 및 이를 이용한 고병원성 조류 인플루엔자 백신 및 제조방법 |
| KR20250137779A (ko) | 2024-03-11 | 2025-09-19 | 대한민국(농림축산식품부 농림축산검역본부장) | Clade 2.3.4.4h에 속하는 재조합 조류 인플루엔자 A 바이러스 합성주, 및 이를 이용한 고병원성 조류 인플루엔자 백신 및 제조방법 |
| US20250288661A1 (en) * | 2024-03-13 | 2025-09-18 | Vst Llc Dba Medgene | Avian influenza virus vaccines |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5174993A (en) | 1981-12-24 | 1992-12-29 | Health Research Inc. | Recombinant avipox virus and immunological use thereof |
| US5505941A (en) | 1981-12-24 | 1996-04-09 | Health Research, Inc. | Recombinant avipox virus and method to induce an immune response |
| EP0575491B1 (fr) | 1991-03-07 | 2003-08-13 | Virogenetics Corporation | Souche de vaccin mise au point par genie genetique |
| FR2728795B1 (fr) | 1994-12-30 | 1997-03-21 | Rhone Merieux | Vaccin vivant recombinant aviaire, utilisant comme vecteur un virus herpes aviaire |
| WO1998016247A1 (fr) | 1996-10-11 | 1998-04-23 | The Regents Of The University Of California | Conjugues polynucleotide immunostimulateur/molecule immunomodulatrice |
| US5980912A (en) | 1997-03-25 | 1999-11-09 | Zonagen, Inc. | Chitosan induced immunopotentiation |
| PL1651265T3 (pl) | 2003-07-24 | 2008-10-31 | Merial Ltd | Formulacje szczepionek zawierających emulsję olej w wodzie |
| US7691368B2 (en) | 2005-04-15 | 2010-04-06 | Merial Limited | Vaccine formulations |
| US7871626B2 (en) * | 2005-08-04 | 2011-01-18 | St. Jude Children's Research Hospital | Modified influenza virus for monitoring and improving vaccine efficiency |
| US8202967B2 (en) | 2006-10-27 | 2012-06-19 | Boehringer Ingelheim Vetmedica, Inc. | H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use |
| US7910112B2 (en) | 2006-11-06 | 2011-03-22 | Merial Limited | Feline vaccines against avian influenza |
| CN101066448A (zh) * | 2007-05-25 | 2007-11-07 | 扬州大学 | 重组鸡痘病毒疫苗rFPV－1218AIH5/H9及其构建方法、用途 |
| FR2921387B1 (fr) * | 2007-09-26 | 2012-04-20 | Sanofi Pasteur | Procede de production du virus de la grippe |
| MX2011005604A (es) * | 2008-11-28 | 2011-09-01 | Merial Ltd | Vacuna recombinante para influenza aviar y sus usos. |
| CN101780275A (zh) | 2009-01-21 | 2010-07-21 | 中国农业科学院哈尔滨兽医研究所 | H5n1亚型禽流感冷适应弱毒活疫苗的研制及其应用 |
| US8871220B2 (en) * | 2009-04-03 | 2014-10-28 | Merial Limited | Newcastle disease virus vectored avian vaccines |
| CN105567648B (zh) * | 2009-04-15 | 2019-09-03 | 法国诗华大药厂 | 用于免疫接种水禽物种的重组禽疱疹病毒载体和疫苗 |
| DK2475384T3 (en) | 2009-09-10 | 2016-10-24 | Merial Inc | NEW VACCINE FORMULATIONS COMPREHENSIVE saponin-CONTAINING ADJUVANTS |
| CN103370079B (zh) * | 2010-10-18 | 2016-08-10 | 英特维特国际股份有限公司 | 针对家禽中禽流感的火鸡疱疹病毒作为载体的疫苗 |
| EP2444441A1 (fr) * | 2010-10-19 | 2012-04-25 | Universiteit van Amsterdam | Procédé pour la préparation de polymère moussant |
| GB2484911B (en) | 2010-10-22 | 2013-04-03 | Johnson Matthey Plc | NOx absorber catalyst comprising caesium silicate and at least one platinum group metal |
| PL220281B1 (pl) * | 2011-09-23 | 2015-09-30 | Inst Biochemii I Biofizyki Polskiej Akademii Nauk | Szczepionka DNA, sposób indukowania odpowiedzi immunologicznej, przeciwciała specyficznie rozpoznające białko hemaglutyniny H5 wirusa grypy i zastosowanie szczepionki DNA |
| HRP20190525T4 (hr) * | 2011-11-30 | 2023-01-20 | Boehringer Ingelheim Animal Health USA Inc. | Rekombinantni vektori gallid herpesvirusa 3 (mdv serotip 2) koji eksprimiraju antigene ptičjih patogena i njihove uporabe |
| JOP20190088A1 (ar) | 2016-10-21 | 2019-04-21 | Us Agriculture | نواقل مؤتلفة للتعبير عن مولدات مضاد فيروس انفلونزا الطيور و استخداماتها |
-
2017
- 2017-06-16 JO JOP/2019/0088A patent/JOP20190088A1/ar unknown
- 2017-10-20 US US15/789,936 patent/US11058761B2/en active Active
- 2017-10-20 EP EP17804329.5A patent/EP3528842B1/fr active Active
- 2017-10-20 TN TNP/2019/000127A patent/TN2019000127A1/en unknown
- 2017-10-20 MA MA046580A patent/MA46580A/fr unknown
- 2017-10-20 WO PCT/US2017/057741 patent/WO2018075977A1/fr not_active Ceased
- 2017-10-20 EP EP24161475.9A patent/EP4378528A3/fr active Pending
- 2017-10-20 KR KR1020197014459A patent/KR20190073460A/ko not_active Ceased
- 2017-10-20 RU RU2019115277A patent/RU2761869C2/ru active
- 2017-10-20 MY MYPI2019002163A patent/MY191322A/en unknown
- 2017-10-20 TW TW106136263A patent/TW201829454A/zh unknown
- 2017-10-20 MX MX2019004593A patent/MX385918B/es unknown
- 2017-10-20 CA CA3041304A patent/CA3041304A1/fr active Pending
- 2017-10-20 ES ES17804329T patent/ES3073368T3/es active Active
- 2017-10-20 CN CN201780077418.4A patent/CN110072548A/zh active Pending
-
2019
- 2019-04-18 IL IL266148A patent/IL266148B2/en unknown
- 2019-04-18 SA SA519401606A patent/SA519401606B1/ar unknown
- 2019-04-22 PH PH12019500854A patent/PH12019500854A1/en unknown
- 2019-04-23 ZA ZA201902525A patent/ZA201902525B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2761869C2 (ru) | 2021-12-13 |
| US20180110852A1 (en) | 2018-04-26 |
| PH12019500854A1 (en) | 2019-08-05 |
| ZA201902525B (en) | 2020-11-25 |
| ES3073368T3 (en) | 2026-07-10 |
| KR20190073460A (ko) | 2019-06-26 |
| CN110072548A (zh) | 2019-07-30 |
| MX2019004593A (es) | 2019-08-14 |
| EP3528842A1 (fr) | 2019-08-28 |
| TW201829454A (zh) | 2018-08-16 |
| TN2019000127A1 (en) | 2020-10-05 |
| MX385918B (es) | 2025-03-18 |
| SA519401606B1 (ar) | 2022-08-25 |
| WO2018075977A1 (fr) | 2018-04-26 |
| CA3041304A1 (fr) | 2018-04-26 |
| IL266148A (en) | 2019-06-30 |
| MY191322A (en) | 2022-06-15 |
| US11058761B2 (en) | 2021-07-13 |
| EP3528842B1 (fr) | 2026-05-27 |
| IL266148B (en) | 2022-10-01 |
| RU2019115277A (ru) | 2020-11-23 |
| JOP20190088A1 (ar) | 2019-04-21 |
| EP4378528A2 (fr) | 2024-06-05 |
| RU2019115277A3 (fr) | 2021-03-10 |
| IL266148B2 (en) | 2023-02-01 |
| EP4378528A3 (fr) | 2024-12-04 |
| EP3528842C0 (fr) | 2026-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL282985B (en) | Modified oncolytic viurs | |
| IL262963A (en) | Tri-segmented pichinde viruses as vaccine vectors | |
| IL272183A (en) | Anti-cd8 antibodies and uses thereof | |
| EP3471767A4 (fr) | Hémagglutinines du virus de la grippe et utilisations de celles-ci | |
| DK3565568T3 (da) | Ændret virus | |
| PT3480307T (pt) | Novos vírus da vacina geneticamente modificados | |
| EP3538146A4 (fr) | Vaccin antigrippal | |
| EP3732191A4 (fr) | Récepteurs antigéniques chimériques améliorés et leurs utilisations | |
| EP3422853A4 (fr) | Insectifuge | |
| EP4219350C0 (fr) | Système de tri de colis et d'articles | |
| IL262092B (en) | Humanized anti-pacap antibodies and uses thereof | |
| EP3463447A4 (fr) | Régimes de vaccination contre le virus de la grippe | |
| EP3658163A4 (fr) | Récepteurs antigéniques chimériques améliorés et leurs utilisations | |
| PT3468990T (pt) | Anticorpos anti-c5 e utilizações dos mesmos | |
| LT3390441T (lt) | Žmogaus imunodeficito virusą neutralizuojantys antikūnai | |
| MA45690A (fr) | Anticorps anti-tgfb, méthodes et utilisations | |
| EP3659614C0 (fr) | Virus de la vaccine oncolytique | |
| EP3497209A4 (fr) | Compositions de poxvirus chimériques et leurs utilisations | |
| EP3362451A4 (fr) | Inhibiteurs de réplication du virus de la grippe, méthodes d'application et utilisations associées | |
| DK3502112T3 (da) | Anti-influenza virus pyrimidinderivat | |
| IL258079B (en) | Antigen receptors and uses thereof | |
| LT3119431T (lt) | Antagonistiniai antikūnai, nukreipti prieš peptidą, susijusį su kalcitonino genu, ir jų panaudojimo būdai | |
| IL266148B (en) | Recombinant vectors expressing avian influenza virus antigens and uses thereof | |
| EP3362929A4 (fr) | Néoépitopes viraux et utilisations de ces derniers | |
| EP3528827A4 (fr) | Vaccins contre la grippe à base de protéine hémagglutinine |